Scientists track rare gene disorders to pave way for future treatments
NCT ID NCT07372833
First seen Feb 01, 2026 · Last updated Jun 23, 2026 · Updated 17 times
Summary
This study follows 150 children and adults worldwide who have ultra-rare mutations in CAMK2 genes, which cause developmental delays, seizures, and autism-like traits. Researchers will collect data on milestones, behavior, and seizures to create detailed disease maps. The goal is to better understand these disorders and identify measures for future clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAMK2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Erasmus MC
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study will create detailed maps of how CAMK2 disorders progress, helping doctors predict outcomes and design future treatments.
What could go wrong
This is an observational study, not a treatment trial. It will not test any drug or therapy, and results may take years to influence care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.